All In Biotech

Drug Trial Radar · NCT04925661

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HEC53856 Capsules in Patients With Non-dialysis Renal Anemia

Last checked: Nov 19, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Nov 4, 2021

Primary completion

Aug 29, 2023

Study completion Aug 29, 2023

Sponsor

Lead sponsor
Sunshine Lake Pharma Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Nicoya Therapeutics (Shanghai) Co., Ltd.
First posted
Jun 14, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety, tolerability , pharmacokinetics and Preliminary Efficacy of HEC53856 Capsules in Patients With Non-dialysis Renal Anemia.

Conditions

  • Chronic Kidney Diseases
  • Renal Anemia

Interventions

  • HEC53856Drug

    Either dose of HEC53856 will be administered after fasting .

  • RoxadustatDrug

    Roxadustat will be administered after fasting .

  • PlaceboDrug

    Either dose of placebo will be administered after fasting .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Adverse EventsTime frame: Through study completion, an average of 12 weeks.

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • The sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China

  • Zhejiang Provincal People's Hospital

    Hangzhou, China

  • The People's Hospital of Guangxi Zhuang Autonmous Region

    Nanning, China

  • Huashan Hospital

    Shanghai, China

  • Ruijin Hospital

    Shanghai, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, China

  • First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China

  • The First Affiliated Hospital of Xiamen University

    Xiamen, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.